Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation

Infection. 2014 Apr;42(2):445-7. doi: 10.1007/s15010-013-0579-8. Epub 2014 Jan 20.

Authors

T Wolf¹, T Kiderlen, J Atta, C Stephan, G Kann, H-R Brodt, C Brandts

Affiliation

¹ Department of Medicine II-Infectious Diseases, HIV Center, Hospital of the J. W. Goethe University, Theodor Stern Kai 7, 60596, Frankfurt, Germany, timo.wolf@kgu.de.

PMID: 24442720
DOI: 10.1007/s15010-013-0579-8

No abstract available

Publication types

Case Reports

MeSH terms

Acquired Immunodeficiency Syndrome / complications
Adult
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Agents / therapeutic use
Central Nervous System Neoplasms / drug therapy*
Central Nervous System Neoplasms / surgery*
Central Nervous System Neoplasms / virology
Epstein-Barr Virus Infections / complications*
Epstein-Barr Virus Infections / drug therapy
Epstein-Barr Virus Infections / surgery
Hematopoietic Stem Cell Transplantation
Herpesvirus 4, Human / isolation & purification
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Lymphoma, Non-Hodgkin / surgery*
Lymphoma, Non-Hodgkin / virology
Male
Methotrexate / therapeutic use
Rituximab
Transplantation, Autologous
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab
Methotrexate